Conditions: Type 2 Diabetes
Keywords: Type 2 Diabetes anion-exchange resin
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 183
Healthy volunteers: no

Brief summary:
The objective of this study is to evaluate the efficacy of MCI-196 in patients with Type 2 Diabetes based on the changes in blood glucose-related parameters and safety after 12 weeks administration in double-blind, placebo-controlled manner. And in addition, the changes in lipid-related parameters are examined.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: MCI-196 intervention 2: Placebo of MCI-196 Tablet
Intervention descriptions: intervention 1: Three tablets of MCI-196 500mg tablet at a time, three times daily, 12 weeks administration (dose in a day: 4500mg) intervention 2: Three tablets of Placebo tablet at a time, three times daily, 12 weeks administration

Protocol document: